Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anteris Technologies Global Corp. Capital/Financing Update 2011

Apr 13, 2011

33869_rns_2011-04-13_c11155b9-21e6-4a09-a727-cf6a708157d4.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [594 x 63] intentionally omitted <==

Innovative BioMedical Devices

bioMD Limited Telephone +61 8 9385 5038 ABN 35 088 221 078 Facsimile +61 8 9385 5028 Unit 9, 589 Stirling Hwy www.biomd.com.au Cottesloe, Western Australia 6010 PO Box 956, Cottesloe Western Australia 6850

ASX RELEASE

14th April 2011

bioMD Offer for Unlisted Allied Medical Limited Market Update

PERTH Australia 14th April 2011: Further to bioMD Limited’s release to the market on 15 February 2011, we wish to advise that we have been granted an extension by the Australian Securities and Investment Commission of the period in which to release our Bidders Statement to the market. The Bidder’s Statement must now be lodged by the earlier of:

  • 2 months and 18 days after the proposal (by 3 May 2011); and

  • 7 Business days after Allied Medical Limited’s December 2010 half yearly financial audit report is signed.

bioMD and Allied Medical Limited are both progressing their respective documentation for their shareholders and will keep the market informed as we proceed.

Yours faithfully

Michael Bennett Managing Director

PERDM01_2665396_1